Neladenoson bialanate

Star0

DB13138InvestigationalSmall molecule

Neladenoson bialanate has been investigated for the treatment of Heart Failure.

Mechanism: Pharmacologically active on Adenosine receptor A1
Curator reviewed
Formula / weight: C₃₅H₃₄ClN₇O₄S₂ · 716.27 g/mol (avg)
Code names: BAY-10-67197

Resolves to

Compound

UNIIIV690462VZCAS1239309-58-0PubChem56848985

Structure

InChIKeyWESNEIGKOAXSGX-VXKWHMMOSA-NSMILESC[C@H](N)C(=O)N[C@@H](C)C(=O)OCCOC1=CC=C(C=C1)C1=C(C#N)C(=NC(SCC2=CSC(=N2)C2=CC=C(Cl)C=C2)=C1C#N)N1CCCC1

Targets

P30542ADORA1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Neladenoson bialanate, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account